Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Placebo-controlled proof-of-concept study of 4% nicotinamide gel in mild to moderate atopic eczema
2011-004184-79Phase 2Completed
- Sponsor
- Dermal Laboratories
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of nicotinamide in atopic dermatitis (AD) (2 arms), sponsored by Dermal Laboratories. Primary endpoint: Change from baseline in Investigator Global Assessment. Started Apr 2013; status: completed.
02
Drugs
nicotinamide
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2011-004184-79.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004184-79.